1) Thiazolidine-2,4-dione
2,4-噻唑烷二酮
2) 2-Thioxo-2,4-thiazolidindione
2-硫代-2,4-噻唑烷二酮
3) 2,4-Diethyl-9H-thioxanthen-9-one
2,4-二乙基噻唑酮
4) thiazolidinedione
噻唑烷二酮
1.
Synthesis of Coumarin-thiazolidinediones;
香豆素噻唑烷二酮类化合物的合成
2.
According to the latest information from the 41~(th) EASD Annual Meeting in 2005,we summarize some noval therapeutic drugs for diabetes,such as non-thiazolidinedione insulin sensitizer incretins,DPP-IV inhibitors,new insulin analogue.
结合2005年欧洲糖尿病年会的最新信息,对近年来已上市和正在试验及研发阶段的新型降糖药物,如非噻唑烷二酮类胰岛素增敏剂、肠促胰岛素、DPP-Ⅳ抑制剂、新型胰岛素类似物等进行综述。
3.
AIM To build a model of two series of PPARγ agonists thiazolidinedione and aryketo-acid derivatives using 3D-QSAR method, and to reveal the structural features affecting the binding activity to PPARγ, which relates to antihyperglycemic and antihyperlipidemic activity and has a potential application to the treatment of type II diabetes.
目的 建立PPARγ激动剂 噻唑烷二酮和芳酮酸类化合物的三维定量构效关系 ,为设计高活性PPARγ激动剂提供结构信息。
5) thiazolidinediones
噻唑烷二酮
1.
Research Advances of Thiazolidinediones;
噻唑烷二酮类药物的研究进展
2.
The clinical observer on diabetes with thiazolidinediones and insulin;
胰岛素与噻唑烷二酮合用临床观察
3.
Peroxisome proliferator-activated receptor-γ agonists or thiazolidinediones(TZD)are a class of agents for the treatment of type 2 diabetes mellitus that act through improvement of insulin sensitivity.
过氧化物酶体增殖物激活受体-γ(PPAR-γ)激动剂-噻唑烷二酮类药物(TZD)是治疗2型糖尿病的一类新药,通过改善胰岛素抵抗而发挥降糖作用。
6) (Z)-5-Benzylidenethiazolidine-2,4-dione
(Z)-5-苯亚甲基-2,4噻唑烷二酮
补充资料：2,4-噻唑烷二酮
分子式：C3H3NO2S
分子量：117.1222
CAS号：2295-31-0
性质：淡白色或类白色粉末。
制备方法：暂无
用途：用于制备吡格列酮、罗格列酮。
分子量：117.1222
CAS号：2295-31-0
性质：淡白色或类白色粉末。
制备方法：暂无
用途：用于制备吡格列酮、罗格列酮。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条